| Auranate Pungprapunpong, PHARM D | |
|
33893 Alcazar Dr, Dana Point, CA 92629-2408 | |
| (949) 493-4479 | |
| Not Available |
| Full Name | Auranate Pungprapunpong |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 33893 Alcazar Dr, Dana Point, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184754913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 43040 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Auranate Pungprapunpong, PHARM D 33893 Alcazar Dr, Dana Point, CA 92629-2408 Ph: (949) 493-4479 | Auranate Pungprapunpong, PHARM D 33893 Alcazar Dr, Dana Point, CA 92629-2408 Ph: (949) 493-4479 |
News Archive
Medicare Part D continues to be a marketplace with an array of competing plans offered at a wide range of premiums and benefit designs. In 2014, Medicare beneficiaries will have a choice of 35 stand-alone PDPs, on average, up by four from 2013. ... Beneficiaries receiving Low-Income Subsidies will have access to a modestly higher number of plans for no monthly premium in 2014 compared to 2013 ... Notable trends for 2014 include a growing share of PDPs using preferred pharmacy networks and adopting more formulary cost-sharing tiers.
United Hayek Industries announced today the release of a new device, The Hayek MRI-RTX, making MRI scans significantly cheaper using synchronized respiratory and cardiac motion. The new device allows coronary MRAs to be performed in half the scan time with higher navigator efficiency.
GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.
"Humanitarian agencies are warning of a looming food crisis in parts of the Central African Republic (CAR), a result of the insecurity that has displaced thousands of people and disrupted cultivation and trade," IRIN reports.
Scientists at Helmholtz Zentrum München have now discovered how Epstein-Barr virus (EBV) conceals itself in human cells. A main culprit for its bad visibility by the immune system is the viral protein LMP2A. As published in the scientific journal PLOS Pathogens, the protein helps EBV-infected cells hide from T cells. This camouflage through the LMP2A protein may play a major role in the causation of cancer by EBV.
› Verified 7 days ago
Sophia Chu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 32900 Pacific Coast Hwy, Dana Point, CA 92629 Phone: 949-489-9030 | |
Avani Kathuria, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 32900 Pacific Coast Hwy, Dana Point, CA 92629 Phone: 949-489-9030 | |
Jiten P Patel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24829 Del Prado, Dana Point, CA 92629 Phone: 949-493-5100 Fax: 949-493-7631 | |
Dr. Amanda Reinharz, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 San Raphael, Dana Point, CA 92629 Phone: 949-444-4741 | |
Mrs. Baochau Sabrina Vu Tran, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 33601 Del Obispo, Dana Point, CA 92629 Phone: 949-496-9490 Fax: 949-496-9501 | |
Elaheh Mehdigholi, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24829 Del Prado, Dana Point, CA 92629 Phone: 949-493-0582 |